A prostate cancer diagnosis can create an immediate sense of urgency. For many men, the first instinct is to have the tumor ...

Did you know that about 1 in 8 men will be diagnosed with prostate cancer during their lifetime? According to the American ...

For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use was ...

Opevesostat (Merck). A first-in-class CYP11A1 inhibitor that shuts down androgen production at its source, opevesostat is in two phase 3 trials, OMAHA-003 and OMAHA-004, for metastatic ...

Prostate cancer screening, test interpretation and treatment decisions can be complex, particularly as new approaches to care ...

Exercise can protect men from the debilitating side-effects of prostate cancer treatment, an NHS trial has found.

ROCHESTER, N.Y. (WROC) – September is Prostate Cancer Awareness Month, and oncologists with Rochester Regional Health are ...

September is Prostate Cancer Awareness Month, a time to remind men to pay attention to an important part of their health that ...

Prostate cancer has many treatment options and a highly effective screening process. This is what doctors what men to know ...

Radiation oncologist Dr. Croix Fossum appeared on Good Morning San Diego to discuss prostate cancer statistics, screening guidelines, and treatment options.

Men diagnosed with nonmetastatic prostate cancer can generally expect to live for many years after their diagnosis. However, ...

US mortality surveillance mirrors the relative burden: 141,733 COPD deaths in 2023 outnumbered prostate and breast cancer ...